Evidence map›Paper›PMID 25058311›Full record

Trial reportJournal of medicinal food2014

High-rosmarinic acid spearmint tea in the management of knee osteoarthritis symptoms.

A Erin Connelly, Amy J Tucker, Hilary Tulk, Marisa Catapang, Lindsey Chapman, Natasha Sheikh, Svitlana Yurchenko, Ron Fletcher, Laima S Kott, Alison M Duncan and 1 more

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of medicinal food, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01380015 (Human Clinical Trial to Investigate the Effects of High Rosmarinic Acid Spearmint Tea on Markers of Pain, Physical Function and Disease Activity in Osteoarthritis of the Knee), which is not on this map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01380015 phase4completednot on this map

Human Clinical Trial to Investigate the Effects of High Rosmarinic Acid Spearmint Tea on Markers of Pain, Physical Function and Disease Activity in Osteoarthritis of the Knee

TypeinterventionalSponsorUniversity of GuelphRan2011 to 2012Enrolled49ConditionsOsteoarthritis of the KneeArmsCommercially spearmint tea, High Rosmarinic Acid Spearmint Tea
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Rosmarinic acid, a natural polyphenol, has a potential pro-oxidant risk via NADH-mediated oxidative DNA damage.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Effects of rosmarinic acid on nervous system disorders: an updated review.Naunyn-Schmiedeberg's archives of pharmacology · 2020
    Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Rosmarinic acid down-regulates NO and PGEJournal of cellular and molecular medicine · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

A Erin Connelly1 Human Nutraceutical Research Unit, Department of Human Health and Nutritional Sciences, College of Biological Sciences, University of Guelph , Guelph, Ontario, Canada .
Amy J Tucker
Hilary Tulk
Marisa Catapang
Lindsey Chapman
Natasha Sheikh
Svitlana Yurchenko
Ron Fletcher
Laima S Kott
Alison M Duncan
Amanda J Wright
University of Guelph · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledIndividuals with medically diagnosed knee osteoarthritis (OA) participated in a randomized, double-blind study to investigate the effects of a high-rosmarinic acid (rosA) spearmint tea. Sixty-two participants were randomized by sex and screening pain score to consume tea brewed from a high-rosA spearmint variety or a commercially available spearmint twice daily for 16 weeks. Pain, quality of life (QoL), and physical function at baseline and week 16 were assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Short-Form 36-item Health Survey (SF-36), 6-minute walk test (6MWT), and stair climb test (SCT). Data from 46 participants (mean age=60.7; BMI=32.9 kg/m(2)) were analyzed. Pain score significantly decreased from week 0 to 16 for the high-rosA group but not for the control group and scores for stiffness and physical disability significantly decreased from week 0 to 16 for both groups. Increased QoL score on the bodily pain index in the SF-36 was observed at week 16 within the high-rosA group only, although no significant differences were observed between the groups. A nonsignificant improvement was observed in the 6MWT at week 16 in the high-rosA group only. There were no changes in the SCT for either group. Therefore, 16-week daily consumption of the high-rosA and commercial spearmint teas significantly improved stiffness and physical disability scores in adults with knee OA, but only the high-rosA tea significantly decreased pain. Consumption of high-rosA tea warrants further consideration as a potential complementary therapy to reduce pain in OA. CLINICAL TRIAL REGISTRATION NUMBER: NCT01380015.

Indexed as

PhytotherapyAgedAnti-Inflammatory Agents, Non-SteroidalCinnamatesDepsidesDouble-Blind MethodFemaleHumansMaleMentha spicataMiddle AgedOsteoarthritis, KneePainPain MeasurementQuality of LifeRosmarinic AcidAnti-Inflammatory Agents, Non-SteroidalCinnamatesDepsidesRosmarinic AcidTea6-minute walk testknee osteoarthritispainrosmarinic acidspearmint teaWOMAC

Identifiers

PMID25058311
PMCPMC4259186
OpenAlexW81007505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.